Bitolterol is a beta-2 adrenergic agonist used to treat asthma and chronic obstructive pulmonary disease (COPD) by dilating the airways. It is grouped under the following drug class(es): Beta-2 agonists and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Tornalate, Bitolterolum, p-Toluic acid and 4-[2-(tert-butylamino)-1-hydroxyethyl]-o-phenylene ester ; S 1540. Its PubChem CID is 35330.
Bitolterol
| CAS No | 30392-40-6 |
|---|---|
| Molecular Formula | C28H31NO5 |
| Molecular Weight | 461.5 g/mol |
| Synonyms | [4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bitolterol is a beta-2 adrenergic agonist used to treat asthma and chronic obstructive pulmonary disease (COPD) by dilating the airways. It is grouped under the following drug class(es): Beta-2 agonists and Bronchodilators.
The listed CAS number is 30392-40-6.
The listed molecular formula is C28H31NO5.
The listed molecular weight is 461.5 g/mol.
[4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate.
The source lists Tornalate, Bitolterolum, p-Toluic acid and 4-[2-(tert-butylamino)-1-hydroxyethyl]-o-phenylene ester ; S 1540.